FULLY HUMAN ANTIBODIES TO BTLA

The present invention relates to binding compounds specific for BTLA and uses thereof. More specifically, the invention relates to fully human antibodies that recognize human BTLA and modulate its activity in cancer, inflammatory, and autoimmune disorders.

Saved in:
Bibliographic Details
Main Authors MATARAZA, JENNIFER, MARIE, THUDIUM, KENT, B, KORMAN, ALAN, J, SELBY, MARK, VAN ELSAS, ANDREA, LEBLANC, HEIDI, N, SPROUL, TIMOTHY, W, HALK, EDWARD, L
Format Patent
LanguageEnglish
French
German
Published 06.06.2012
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to binding compounds specific for BTLA and uses thereof. More specifically, the invention relates to fully human antibodies that recognize human BTLA and modulate its activity in cancer, inflammatory, and autoimmune disorders.
Bibliography:Application Number: EP20100737222